Impact Factor
3.77
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.58
320 total citations
h5-index
25
h5 depth signal
Cited share
84.7%
50 of 59
Total citations
320
Citation footprint
Metric signal
7.02
External metric anchor
Self-citation
0.3%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Canada
92
United States
83
China
53
Japan
49
Iran
43
Citing Fields of Research
Pharmacology & Toxicology
97
Drug Delivery Systems
69
Medical Ethics
43
Cancer Drugs
33
Cardiology
29
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
827
Articles tracked across the journal lifetime
Indexed publication set
59
50 cited publications
Last 12 months
38
3.5 publications/month
Open access share
100.0%
38 OA publications in the last year
Leading citing country
Canada
92 citing publications
Leading citing field
Pharmacology & Toxicology
97 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v1n1,Jan.-Apr. 1998-
v1n1,Jan.-Apr. 1998-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Drug Delivery Systems
Pharmacology & Toxicology
Patient Care
Wounds & Ulcers
Antibiotic & Antibacterial Agents
Diabetes
Issuing & Sponsoring Bodies
Contributor
Canadian Society for Pharmaceutical Sciences
Broad Categories
Pharmacology
Pharmacy
Diabetes
Medical Ethics
Drug Delivery Systems
Antibiotic & Antibacterial Agents
Mass Spectrometry
Hematology
MeSH Descriptors
Drug Therapy
Pharmaceutical Preparations
Technology, Pharmaceutical
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.3389/jpps.2026.17216
Open DOI
Integrated computational screening and biochemical validation identify natural small molecules targeting Aβ aggregation and dissociation
Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β (Aβ), a pathological hallmark implicated in disease onset and progression. Aβ undergoes self-assembly from monomers into soluble oligomers, protofibrils, insolubl...
02
DOI 10.3389/jpps.2026.17048
Open DOI
Bioequivalence of budesonide inhalation suspension with and without activated charcoal in healthy Chinese subjects: two randomized four-period crossover trials
Background: Demonstrating bioequivalence for locally acting inhaled products is challenging because systemic exposure may reflect both pulmonary absorption and gastrointestinal absorption of the swallowed fraction. Activated charcoal can...
03
DOI 10.3389/jpps.2026.17560
Open DOI
Diabesity: an old term, a modern challenge — multi-omics and precision anti-obesity pharmacotherapy in type 2 diabetes
Type 2 diabetes mellitus (T2DM) and obesity are closely interconnected but heterogeneous conditions in which treatment response, safety, body weight, glycemic control, and long-term clinical outcomes vary substantially between individual...
04
DOI 10.3389/jpps.2026.16471
Open DOI
A mechanistic quantitative systems pharmacology framework for glucosamine sulfate in knee osteoarthritis: linking exposure, cartilage biology, and clinical outcomes
Background: Glucosamine is widely used for osteoarthritis management, yet clinical trial results remain controversial, despite robust preclinical anti-inflammatory effects that fail to translate consistently into clinical benefit. We hyp...
05
DOI 10.3389/jpps.2026.16205
Open DOI
The pharmaceutical applications of palm kernel oil: innovations in dermatological therapies
Dermatological problems of the skin, hair or nails are considered one of the most cutaneous complaints and form around 30% of all visits to dermatologists. Recent treatments have been focused on exploring natural agents as alternatives f...
06
DOI 10.3389/jpps.2026.17336
Open DOI
Carbapenem-based versus non-carbapenem therapy for hospital-acquired and ventilator-associated pneumonia in a resource-limited setting: a retrospective cohort study of clinical outcomes
Background: Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are major causes of in-hospital mortality and antimicrobial resistance (AMR), particularly in low- and middle-income countries (LMICs). Carbapenems a...
07
DOI 10.3389/jpps.2026.17413
Open DOI
Availability, utilization, and factors associated with professional pharmacy services in community pharmacies in Saudi Arabia: a cross-sectional study
Background: Community pharmacists are increasingly expected to provide patient-centered clinical and public health services beyond traditional medication dispensing. However, the availability and utilization of these services in Saudi co...
08
DOI 10.3389/jpps.2026.17260
Open DOI
Effects of music elements on mycophenolate glucuronidation in rat liver microsomes
Background: Mycophenolic acid (MPA), a first-line immunosuppressant for preventing transplant organ rejection, exhibits substantial inter- and intra-individual pharmacokinetic variability. We hypothesized that music elements (tempo, rhyt...
09
DOI 10.3389/jpps.2026.16454
Open DOI
Integration of microphysiological systems with computational and digital twin modeling for pharmaceutical development: a systematic review
Background: The pharmaceutical industry faces a productivity crisis, with only ∼10% of candidates reaching approval and development costs exceeding $1-2 billion per drug. Traditional preclinical models, particularly animal studies, show ...
10
DOI 10.3389/jpps.2026.16879
Open DOI
Age-related risk factors for leftover drugs: a lifespan analysis in community pharmacies
Introduction: Medication adherence is a critical global challenge because suboptimal adherence reduces therapeutic efficacy and increases healthcare costs. While leftover drugs are vital indicators of potential adherence-related challeng...
Bibliographical & Catalog Notes
Title from contents page (viewed May 22, 2000).
Mode of access: Internet.